戻る Agenda
Session 4 (Parallel Session) : Drug Development with Innovative Technology
Session Chair(s)
Hyesook Park
Head, General Manager, CMIC Korea, Korea, Republic of
Kyuho Oh
Vice President, KCRO Association, Korea, Republic of
Speaker(s)
Hyunjin Shin, PhD
President, MOGAM Institute for Biomedical Research, Korea, Republic of
EunSung Cho, PhD
Founder and CEO, inCerebro, Korea, Republic of
Ji-Hyun Lee, PhD
CEO, DR. NOAH Biotech, Korea, Republic of
Donald G Jennings, MBA, MS
Manager IT, Eli Lilly, United States